Traxion Sab De Cv Ord Shs GRPOF

TBP & WARANTS to begin listing/TRADING on tsx as of AUG 4TH

[Humanist]

Tetra Bio-Pharma Announces Expected Effective Date of Listing on TSX of its Common Shares and Warrants

by @newswire on 30 Jul 2020, 09:03

    OTTAWA, ON, July 30, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSXV: TBP) (OTCQB: TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that the previously announced graduation of the Corporation's common shares (the "Common Shares") and listed warrants (the "Warrants") is expected to occur on August 4, 2020.
The Corporation previously announced on July 15, 2020 that it had received conditional approval from the Toronto Stock Exchange ("TSX") to graduate from the TSX-Venture Exchange ("TSX-V"), where the Common Shares and certain of its Warrants are currently listed, subject to satisfying certain standard listing requirements.
The graduation is expected to occur on August 4, 2020, and the Common Shares and Warrants are expected to be listed and commence trading on the TSX at the opening of markets on same date under the symbols "TBP", "TBP.WT", "TBP.WT.A" and "TBP.WT.B", respectively. In connection with such graduation, the Corporation's Common Shares and listed Warrants will be voluntarily delisted from the TSX-V. The Common Shares will continue to trade on the OCTQB market under the symbol "TBPMF".

The Common Shares and Warrants have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws.
This press release does not constitute an offer to sell or a solicitation of any offer to buy the securities in the United States, in any province or territory of Canada or in any other jurisdiction. There shall be no sale of the securities in any jurisdiction in which an offer to sell, a solicitation of an offer to buy or sale would be unlawful.
About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Corporation has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.